Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery
- PMID: 29765197
- PMCID: PMC5939878
- DOI: 10.2147/OPTH.S155631
Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery
Erratum in
-
Erratum: Impact of conjunctival autograft on pterygium treatment: evaluation of related symptoms and patients' satisfaction after surgery [Corrigendum].Clin Ophthalmol. 2018 Jul 17;12:1267. doi: 10.2147/OPTH.S174821. eCollection 2018. Clin Ophthalmol. 2018. PMID: 30050278 Free PMC article.
Abstract
Purpose: Pterygium is a fibrovascular condition of the ocular surface that can cause a broad range of irritative and visual symptoms. Controversy exists regarding pterygium mechanisms, management, surgical techniques, adjuvant approaches and impact on patients' quality of life. We performed a retrospective survey focused on the impact of pterygium-related symptoms before surgery and patients' satisfaction after excision surgery followed by conjunctival autograft transplantation with fibrin glue, based on patients' subjective reporting.
Methods: All patients underwent surgery consisting of the extensive removal of the pterygium fibrovascular tissue, followed by autologous conjunctival graft fixed with fibrin glue to cover the bare scleral area. A total of 500 patients were contacted by phone call and invited to participate in the study answering a brief two-question survey. First, to grade overall intensity of symptoms related to pterygium before surgical intervention, such as pain, irritation, tearing, red eye, photophobia, burning and foreign body sensation, using a scale from 0 to 10 (0 asymptomatic and 10 very severe symptoms). Results were categorized as mild (0-3), moderate (4-7) and severe (8-10). Then, patients were asked about their satisfaction with the surgery outcome, also using a scale from 0 to 10 (ranging from dissatisfied to fully satisfied).
Results: Patients' mean age was 41.5±12.31 (min 18/max 83) years old and the mean of days after surgery was 1,493±552.7 (min 711/max 2,702). Symptoms were referred to as severe (70.2%), moderate (25.2%) and mild (4.6%). After surgery, most patients were fully satisfied and the mean grade was 9.6; 1% (0-3), 2.4% (4-7) and 96.6% (8-10). Women presented a higher score of symptoms compared to men (P<0.01) but similar satisfaction rates.
Conclusions: The present study shows that pterygium greatly impacts on patients' quality of life and that excision surgery using conjunctival autograft transplantation and fibrin glue improved symptoms with high rates of satisfaction.
Keywords: autologous conjunctival graft; fibrin glue; pterygium; quality of life; surgery; symptoms.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




Similar articles
-
Limbal stem cell transplantation: an evidence-based analysis.Ont Health Technol Assess Ser. 2008;8(7):1-58. Epub 2008 Oct 1. Ont Health Technol Assess Ser. 2008. PMID: 23074512 Free PMC article.
-
Comparison of fibrin glue with sutures for pterygium excision surgery with conjunctival autografts.Clin Exp Ophthalmol. 2009 Aug;37(6):584-9. doi: 10.1111/j.1442-9071.2009.02105.x. Clin Exp Ophthalmol. 2009. PMID: 19702708 Clinical Trial.
-
Evicel versus Tisseel versus Sutures for Attaching Conjunctival Autograft in Pterygium Surgery: A Prospective Comparative Clinical Study.Ophthalmology. 2017 Jan;124(1):61-65. doi: 10.1016/j.ophtha.2016.09.010. Epub 2016 Nov 3. Ophthalmology. 2017. PMID: 27817915 Clinical Trial.
-
Autologous Blood for Conjunctival Autograft Fixation in Primary Pterygium Surgery: A Systematic Review and Meta-analysis.Curr Pharm Des. 2018;24(35):4197-4204. doi: 10.2174/1381612824666181001161352. Curr Pharm Des. 2018. PMID: 30277146
-
Options and adjuvants in surgery for pterygium: a report by the American Academy of Ophthalmology.Ophthalmology. 2013 Jan;120(1):201-8. doi: 10.1016/j.ophtha.2012.06.066. Epub 2012 Oct 11. Ophthalmology. 2013. PMID: 23062647 Review.
Cited by
-
Cost-Effective Surgical Management of Pterygium: A Blood-Based Adhesion Technique Substituting Fibrin Glue.Cureus. 2024 Apr 7;16(4):e57786. doi: 10.7759/cureus.57786. eCollection 2024 Apr. Cureus. 2024. PMID: 38721195 Free PMC article.
-
Conjunctival Autograft With Fibrin Glue for Pterygium: A Long Term Recurrence Assessment.Med Hypothesis Discov Innov Ophthalmol. 2019 Winter;8(4):272-277. Epub 2019 Oct 1. Med Hypothesis Discov Innov Ophthalmol. 2019. PMID: 31788488 Free PMC article.
-
Subconjunctival dexamethasone-assisted conjunctival autograft harvesting versus normal saline during pterygium surgery - A randomized clinical trial.Indian J Ophthalmol. 2024 Feb 1;72(2):217-222. doi: 10.4103/IJO.IJO_969_23. Epub 2023 Dec 15. Indian J Ophthalmol. 2024. PMID: 38099381 Free PMC article. Clinical Trial.
-
Recurrence Rate and Clinical Outcome of Amniotic Membrane Transplantation Combined with Mitomycin C in Pterygium Surgery: Two-Year Follow-Up.J Res Pharm Pract. 2020 Mar 28;9(1):10-15. doi: 10.4103/jrpp.JRPP_19_127. eCollection 2020 Jan-Mar. J Res Pharm Pract. 2020. PMID: 32489955 Free PMC article.
-
Ocular surface squamous neoplasia in a patient following oral steroids for contralateral necrotising scleritis.BMJ Case Rep. 2022 Dec 15;15(12):e253300. doi: 10.1136/bcr-2022-253300. BMJ Case Rep. 2022. PMID: 36521875 Free PMC article.
References
-
- Bradley JC, Yang W, Bradley RH, Reid TW, Schwab IR. The science of pterygia. Br J Ophthalmol. 2010;94(7):815–820. - PubMed
-
- Ang M, Li X, Wong W, et al. Prevalence of and racial differences in pterygium: a multiethnic population study in Asians. Ophthalmology. 2012;119(8):1509–1515. - PubMed
-
- Shiroma H, Higa A, Sawaguchi S, et al. Prevalence and risk factors of pterygium in a southwestern island of Japan: the Kumejima Study. Am J Ophthalmol. 2009;148(5):766–771.e1. - PubMed
-
- Hirst LW. The treatment of pterygium. Surv Ophthalmol. 2003;48(2):145–180. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous